Skip to content

13F-HR filed by ISZO CAPITAL MANAGEMENT LP

ISZO CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 10 holding rows worth $18,812,143.

Accession
0001013594-23-000495
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 10 entries on the cover page, a total value of $18,812,143 stated on the cover page (in dollars after the unit check, H1), rows summing to $18,812,143 with VALUE read as dollars as filed, 13F file number 028-16140. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LANTHEUS HLDGS INC516544103COM100,000$8,256,000dollars as filed
CBL & ASSOC PPTYS INC012430878COMMON STOCK82,081$2,104,557dollars as filed
NOVARTIS AG SPONSORED ADR66987V109ADR22,000$2,024,000dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock9,000$2,015,640dollars as filed
INVESCO QQQ TR46090E103COM4,800$1,540,464dollars as filed
NOVO-NORDISK A S ADR670100205ADR7,000$1,113,980dollars as filed
SPY78462F103SHS2,500$1,023,475dollars as filed
FIRST REPUBLIC BANK/SAN FRANCI33616C100COM52,000$727,480dollars as filed
Amplify Energy Corp03212B103COM953$6,547dollars as filed
GLOBAL CORD BLOOD CORPG39342103COM279,495$0dollars as filedValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-23-000495this filing2023-05-15acceptance time not in the bulk data set